Dr. Julius Fredens holds a Presidential Young Professorship at NUS and is a Principal Investigator in the NUS Synthetic Biology Translational Research Programme. He received his PhD from University of Southern Denmark, where he developed SILAC for quantitative proteomics in C. elegans, under the supervision of Nils Færgeman. As a postdoc with Jason Chin at LMB in Cambridge, he co-authored the first synthetic E. coli genome with a compressed genetic code, and demonstrated its genetic resistance to bacteriophage.  Julius is interested in synthetic biology with applications in therapy, biotech, and sustainable production. Not to mention jazz and bread baking.